A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 
5-monophosphate conjugated with lactosaminated albumin

Fiume, L.; Bassi , B.; Busi, C.; Mattioli, A.; Wieland, Theodor

doi:10.1007/BF01952078

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 5-monophosphate conjugated with lactosaminated albumin

MPS-Authors

/persons/resource/persons206380

Fiume, L.
Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons197838

Wieland, Theodor
Max Planck Institute for Medical Research, Max Planck Society;

External Resource

https://link.springer.com/content/pdf/10.1007%2FBF01952078.pdf
(Any fulltext)

https://doi.org/10.1007/BF01952078
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Fiume, L., Bassi, B., Busi, C., Mattioli, A., & Wieland, T. (1985). A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 5-monophosphate conjugated with lactosaminated albumin. Experientia: interdisciplinary journal for the life sciences, 41(10), 1326-1328. doi:10.1007/BF01952078.

Cite as: https://hdl.handle.net/21.11116/0000-0005-9963-F

Abstract

In plasma of mice injected with adenine-9-beta-D-arabinofuranoside monophosphate (ara-AMP) coupled to human lactosaminated serum albumin (L-HSA) some of the ara-AMP molecules are enzymatically released, whereas others remain linked to L-HSA. Evidence has been obtained that ara-AMP is not deaminated when it is conjugated to L-HSA, in contrast to the free drug which is rapidly metabolized to its hypoxanthine derivative.